Aldeyra Therapeutics, Inc. (ALDX)
USD 4.88
(-8.44%)
USD 4.88
(-8.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 262.78 Thousand | 258.7 Thousand | 264.18 Thousand | 56.22 Thousand | 96.3 Thousand | 71 Thousand |
| Gross Profit | -262.78 Thousand | -258.7 Thousand | -264.18 Thousand | -56.22 Thousand | -96.3 Thousand | -71 Thousand |
| Operating Expenses | 42.79 Million | 62.67 Million | 56.21 Million | 34.66 Million | 56.5 Million | 39.69 Million |
| Selling, General and Administrative Expenses | 13.33 Million | 15.37 Million | 11.28 Million | 9.98 Million | 12.15 Million | 9.87 Million |
| Research and Development Expenses | 29.45 Million | 47.3 Million | 44.93 Million | 24.68 Million | 44.35 Million | 29.82 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 42.79 Million | 62.67 Million | 56.21 Million | 34.66 Million | 56.5 Million | 39.69 Million |
| Operating Income | -42.79 Million | -62.67 Million | -56.21 Million | -36.42 Million | -63.07 Million | -39.69 Million |
| Interest Expense | 2.07 Million | 1.69 Million | 1.74 Million | 1.9 Million | 603.84 Thousand | 146.79 Thousand |
| Income Tax Expense | - | -655.35 Thousand | 1.47 Million | -479.26 Thousand | -1.3 Million | 952.69 Thousand |
| Earnings before Tax | -37.54 Million | -62.02 Million | -57.77 Million | -38.03 Million | -62.13 Million | -38.89 Million |
| Net Income | -37.54 Million | -61.36 Million | -59.25 Million | -37.55 Million | -60.82 Million | -38.89 Million |
| Earnings Per Share Basic | -0.64 | -1.05 | -1.10 | -1.11 | -2.24 | -1.79 |
| Earnings Per Share Diluted | -0.64 | -1.05 | -1.10 | -1.11 | -2.24 | -1.79 |
| Weighted Average Shares Outstanding | 58.94 Million | 58.4 Million | 54.04 Million | 33.96 Million | 27.11 Million | 21.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.94 Million | 58.4 Million | 54.04 Million | 33.96 Million | 27.11 Million | 21.68 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -35.2 Million | -60.07 Million | -55.76 Million | -36.07 Million | -61.43 Million | -38.67 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 392.62 Thousand | - | - |
| Cost of Revenue | 61.63 Thousand | 60.63 Thousand | 262.78 Thousand | 66.46 Thousand | 64.99 Thousand | 64.33 Thousand |
| Gross Profit | -61.63 Thousand | -60.63 Thousand | -262.78 Thousand | 326.15 Thousand | -64.99 Thousand | -64.33 Thousand |
| Operating Expenses | 17.94 Million | 9.33 Million | 42.53 Million | 6.03 Million | 9.55 Million | 10.34 Million |
| Selling, General and Administrative Expenses | 2.97 Million | 3.14 Million | - | 1.73 Million | 2.58 Million | 3.37 Million |
| Research and Development Expenses | 14.96 Million | 6.18 Million | - | 4.29 Million | 6.96 Million | 6.96 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 18 Million | 9.39 Million | 42.79 Million | 6.09 Million | 9.55 Million | 10.34 Million |
| Operating Income | -18 Million | -9.39 Million | -42.79 Million | -6.09 Million | -9.55 Million | -10.34 Million |
| Interest Expense | 477.6 Thousand | 498.52 Thousand | 2.07 Million | 514.26 Thousand | 538.74 Thousand | 527.14 Thousand |
| Income Tax Expense | -1.00 | -2.00 | - | -3.08 Million | 1.9 Million | 1.88 Million |
| Earnings before Tax | -16.84 Million | -8.08 Million | -37.54 Million | -4.75 Million | -8.18 Million | -8.98 Million |
| Net Income | -16.84 Million | -8.08 Million | -37.54 Million | -4.75 Million | -8.18 Million | -8.98 Million |
| Earnings Per Share Basic | -0.28 | -0.14 | - | -0.08 | -0.14 | -0.15 |
| Earnings Per Share Diluted | -0.28 | -0.14 | - | -0.08 | -0.14 | -0.15 |
| Weighted Average Shares Outstanding | 59.41 Million | 59.41 Million | 58.94 Million | 59.19 Million | 58.99 Million | 58.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.41 Million | 59.41 Million | 58.94 Million | 59.19 Million | 58.99 Million | 58.79 Million |
| Gross Margin | - | - | - | 0.83 | - | - |
| EBIT Margin | - | - | - | -15.36 | - | - |
| Profit Margin | - | - | - | -12.11 | - | - |
| EBITDA | -17.94 Million | -9.33 Million | - | -6.03 Million | -7.58 Million | -8.39 Million |
| Earnings Before Tax Margin | - | - | - | -15.53 | - | - |
BYAGF
OTLC
CLX
8254
VSOGF
3823